Global M&A activity so far this year is at its highest level since the financial crisis, expert analysis has revealed.
Some $705bn of deals have been announced since the start of 2017, the first.. City A.M.
Feb.06 -- Bloomberg’s Jeff McCracken discusses global deal activity in January, President Trump’s tax proposals and mergers and acquisitions in an unpredictable market. He speaks on “Bloomberg.. Source: Bloomberg Global Business -
Johnson & Johnson is enacting at $30 billion takeover of Europe’s biggest biotech company, Actelion. Johnson & Johnson is known for buying Swiss medical companies, and those who own stock in the.. Source: Wochit Headline News -
Actelion Pharmaceuticals had a very attractive pipeline of new drugs in development. But OPAP, a Greek lottery and sports betting operator, was hit hard by the political crisis in the country. MailOnline
ZURICH (Reuters) - A European Medicines Agency drug safety panel recommended on Friday that Actelion's Uptravi drug may continue to be used in line with current prescription information amid a probe.. Reuters
* J&J - upon termination of transaction agreement, under some circumstances, Actelion may be obligated to pay co a fee - sec filing Source text - http://bit.ly/2jWFeAh Further company coverage: Reuters
ZURICH (Reuters) - The looming foreign takeovers of biotech group Actelion and agrichemicals firm Syngenta look set to trigger the biggest shake-up in the Swiss blue-chip SMI index in years just as.. Reuters
LONDON, Jan 26 (Reuters) - Advisers could pocket up to $100 million in fees from Johnson & Johnson's $30 billion acquisition of Swiss biotech firm Actelion, the largest takeover of a European... Reuters
So this morning Johnson & Johnson bought Europe's biggest healthcare firm in a $31bn (£23.7bn) transaction in what was the biggest M&A deal announced so far in 2017.
Which are the other big deals.. City A.M.